CASPR2 inhibitors belong to a specialized category of chemical compounds designed to modulate cellular processes associated with the Contactin-associated protein-like 2 (CASPR2) protein. CASPR2, also known as CNTNAP2, is a transmembrane protein primarily expressed in the nervous system, particularly in neurons. It plays a crucial role in the formation and maintenance of neural circuits, influencing synaptic function and neuronal connectivity. The chemical class of CASPR2 inhibitors is characterized by its ability to interact with CASPR2 and interfere with its normal cellular functions.
The molecular structure of CASPR2 inhibitors is designed to selectively target the binding sites or signaling domains of CASPR2, impeding its interactions with other proteins or altering its conformation. By doing so, these inhibitors modulate the downstream signaling cascades associated with CASPR2, potentially affecting synaptic transmission, neuronal migration, and axon guidance. The rationale behind developing CASPR2 inhibitors often stems from the desire to better understand the intricate molecular mechanisms governing neural development and function. Researchers aim to leverage these inhibitors as valuable tools for dissecting the roles of CASPR2 in cellular processes, contributing to a deeper comprehension of neurobiology and potentially unveiling novel insights into the regulation of neural circuits. The chemical class of CASPR2 inhibitors thus serves as a valuable resource for advancing our knowledge of molecular neurobiology, providing researchers with precise means to manipulate CASPR2-mediated processes for experimental exploration and scientific discovery.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium can affect GSK-3β signaling, potentially altering intracellular events that may impact CASPR2. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
BAY 11-7082 inhibits NF-κB, which can influence neuronal signaling pathways associated with CASPR2. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 inhibits MEK, which is part of the MAPK/ERK pathway, potentially affecting CASPR2 interactions. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 inhibits p38 MAPK, and may influence signaling pathways that interact with CASPR2 indirectly. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 inhibits PI3K and can affect downstream signaling pathways related to CASPR2. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, which can influence signaling pathways that indirectly modulate CASPR2. | ||||||
Casein Kinase I Inhibitor, D4476 | 301836-43-1 | sc-202522 | 1 mg | $97.00 | 6 | |
D4476 is a CK1 inhibitor, which may impact Wnt signaling and thus indirectly affect CASPR2 functions. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, which may have downstream effects on cellular processes involving CASPR2. | ||||||
Wnt-C59 | 1243243-89-1 | sc-475634 sc-475634A sc-475634B | 5 mg 10 mg 50 mg | $210.00 $320.00 $1250.00 | 1 | |
Wnt-C59 inhibits Wnt production, potentially affecting pathways that CASPR2 is involved in. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $35.00 $115.00 $515.00 | 26 | |
XAV-939 inhibits Wnt/β-catenin signaling, which may indirectly influence CASPR2-related signaling. | ||||||